Literature DB >> 12878550

Artemisinin and heme.

Steven R Meshnick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12878550      PMCID： PMC166080          DOI： 10.1128/AAC.47.8.2712-2713.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  15 in total

1.  Characterization of the Alkylation Product of Heme by the Antimalarial Drug Artemisinin We are grateful to the CNRS for financial support, and to the French Ministery of Education for a PhD grant to J.C. Dr. Yannick Coppel (LCC-CNRS) is gratefully acknowledged for discussions on NMR data.

Authors:  Anne Robert; Jérôme Cazelles; Bernard Meunier
Journal:  Angew Chem Int Ed Engl       Date:  2001-05-18       Impact factor: 15.336

2.  Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite.

Authors:  A V Pandey; B L Tekwani; R L Singh; V S Chauhan
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

Review 3.  Artemisinin: mechanisms of action, resistance and toxicity.

Authors:  Steven R Meshnick
Journal:  Int J Parasitol       Date:  2002-12-04       Impact factor: 3.981

Review 4.  How might qinghaosu (artemisinin) and related compounds kill the intraerythrocytic malaria parasite? A chemist's view.

Authors:  Yikang Wu
Journal:  Acc Chem Res       Date:  2002-05       Impact factor: 22.384

Review 5.  Possible modes of action of the artemisinin-type compounds.

Authors:  P L Olliaro; R K Haynes; B Meunier; Y Yuthavong
Journal:  Trends Parasitol       Date:  2001-03

6.  Effects of antimalarials and protease inhibitors on plasmodial hemozoin production.

Authors:  W Asawamahasakda; I Ittarat; C C Chang; P McElroy; S R Meshnick
Journal:  Mol Biochem Parasitol       Date:  1994-10       Impact factor: 1.759

7.  Alkylation of human albumin by the antimalarial artemisinin.

Authors:  Y Z Yang; W Asawamahasakda; S R Meshnick
Journal:  Biochem Pharmacol       Date:  1993-07-20       Impact factor: 5.858

8.  The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin.

Authors:  J Bhisutthibhan; X Q Pan; P A Hossler; D J Walker; C A Yowell; J Carlton; J B Dame; S R Meshnick
Journal:  J Biol Chem       Date:  1998-06-26       Impact factor: 5.157

9.  Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure.

Authors:  Y Z Yang; B Little; S R Meshnick
Journal:  Biochem Pharmacol       Date:  1994-08-03       Impact factor: 5.858

10.  Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu).

Authors:  S R Meshnick; Y Z Yang; V Lima; F Kuypers; S Kamchonwongpaisan; Y Yuthavong
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191
View more
  8 in total

1.  Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling.

Authors:  Kalvin Q Tran; Antony S Tin; Gary L Firestone
Journal:  Anticancer Drugs       Date:  2014-03       Impact factor: 2.248

2.  Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells.

Authors:  Shyam N Sundar; Crystal N Marconett; Victor B Doan; Jamin A Willoughby; Gary L Firestone
Journal:  Carcinogenesis       Date:  2008-09-10       Impact factor: 4.944

3.  Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: A possible link.

Authors:  Gerald Geroldinger; Matthias Tonner; Judith Quirgst; Martin Walter; Sritama De Sarkar; Laura Machín; Lianet Monzote; Klaus Stolze; J Catharina Duvigneau; Katrin Staniek; Mitali Chatterjee; Lars Gille
Journal:  Biochem Pharmacol       Date:  2019-11-29       Impact factor: 5.858

4.  Evidence for the contribution of the hemozoin synthesis pathway of the murine Plasmodium yoelii to the resistance to artemisinin-related drugs.

Authors:  Benoit Witkowski; Joel Lelièvre; Marie-Laure Nicolau-Travers; Xavier Iriart; Patrice Njomnang Soh; Fatima Bousejra-Elgarah; Bernard Meunier; Antoine Berry; Françoise Benoit-Vical
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

5.  Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium falciparum Strains.

Authors:  Tuo Yang; Stanley C Xie; Pengxing Cao; Carlo Giannangelo; James McCaw; Darren J Creek; Susan A Charman; Nectarios Klonis; Leann Tilley
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

6.  Two distinct and competitive pathways confer the cellcidal actions of artemisinins.

Authors:  Chen Sun; Jian Li; Yu Cao; Gongbo Long; Bing Zhou
Journal:  Microb Cell       Date:  2015-01-02

Review 7.  Biological actions of artemisinin: insights from medicinal chemistry studies.

Authors:  Jian Li; Bing Zhou
Journal:  Molecules       Date:  2010-03-08       Impact factor: 4.411

8.  In Vitro and In Silico Antimalarial Evaluation of FM-AZ, a New Artemisinin Derivative.

Authors:  Ioannis Tsamesidis; Farnoush Mousavizadeh; Chinedu O Egwu; Dionysia Amanatidou; Antonella Pantaleo; Françoise Benoit-Vical; Karine Reybier; Athanassios Giannis
Journal:  Medicines (Basel)       Date:  2022-01-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.